The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2019

Filed:

Aug. 31, 2016
Applicants:

Ureka Sarl, Mulhouse, FR;

Centre National DE LA Recherche Scientifique (Cnrs), Paris, FR;

Inventors:

Gilles Guichard, Gradignan, FR;

Gavin W. Collie, Aberdeenshire, GB;

Karolina Pulka-Ziach, Warsaw, PL;

Caterina Maria Lombardo, Sora, IT;

Juliette Fremaux, Pessac, FR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 7/02 (2006.01); A61K 38/10 (2006.01); A61K 47/59 (2017.01); A61K 47/18 (2017.01); C07C 275/16 (2006.01); C07D 207/09 (2006.01); C08L 75/02 (2006.01);
U.S. Cl.
CPC ...
C07K 7/02 (2013.01); A61K 38/10 (2013.01); A61K 47/18 (2013.01); A61K 47/59 (2017.08); C07C 275/16 (2013.01); C07D 207/09 (2013.01); C08L 75/02 (2013.01);
Abstract

The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.


Find Patent Forward Citations

Loading…